NCT05685407View on ClinicalTrials.gov

Examining Caffeine as a Treatment for Antidepressant-induced Arousal Dysfunction in Women

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

April 15, 2023

Study Completion Date

April 15, 2023

Conditions
Female Sexual Arousal Disorder
Interventions
DRUG

Caffeine

300mg caffeine will be administered orally via capsules to participants with female sexual arousal disorder.

OTHER

Placebo

A placebo pill that matches in size, shape, and color will be administered to participants with female sexual arousal disorder.

Trial Locations (1)

78712

The University of Texas at Austin, Sexual Psychophysiology Laboratory, Austin

All Listed Sponsors
lead

University of Texas at Austin

OTHER